当前位置: X-MOL 学术Ann. Noninvasive Electrocardiol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Should beta-blockers be continued as a treatment for myocardial infarction in the case of Kounis syndrome?
Annals of Noninvasive Electrocardiology ( IF 1.1 ) Pub Date : 2021-03-30 , DOI: 10.1111/anec.12837
Mari Amino 1, 2 , Tomokazu Fukushima 2 , Atsushi Uehata 2 , Chiemi Nishikawa 2 , Seiji Morita 2 , Yoshihide Nakagawa 2 , Tsutomu Murakami 1 , Koichiro Yoshioka 1 , Yuji Ikari 1
Affiliation  

A 71-year-old male patient reported to our hospital with anaphylactic shock, and the following two issues were focused in this case. First, he was resistant to adrenaline because of taking beta-blocker, and shock was repeated until glucagon administration was initiated. Second, he developed acute coronary syndrome. Two mechanisms contributing to Kounis syndrome were differentiated: 1) adrenaline induced coronary spasm and platelet activation or 2) a mismatch between oxygen supply and demand due to an allergic reaction. Beta-blocker therapy was discontinued because his cardiac function was preserved. Secondary preventive beta-blockers in recovering myocardial infarction with severe anaphylaxis history should be carefully considered.

中文翻译:

对于 Kounis 综合征,是否应该继续使用 β 受体阻滞剂治疗心肌梗死?

一名71岁男性患者向我院报告过敏性休克,该病例主要关注以下两个问题。首先,由于服用β受体阻滞剂,他对肾上腺素产生抵抗力,并且反复休克,直到开始给予胰高血糖素。其次,他患上了急性冠状动脉综合症。导致 Kounis 综合征的两种机制有所不同:1)肾上腺素诱导冠状动脉痉挛和血小板活化,或 2)由于过敏反应导致氧气供需不匹配。由于他的心脏功能得以保留,β-受体阻滞剂治疗被终止。对于有严重过敏反应史的心肌梗死恢复期,应仔细考虑使用二级预防性β受体阻滞剂。
更新日期:2021-03-30
down
wechat
bug